Carolina B. Belli

Av. Orlando Marques De Paiva, 87, 05508-270
Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Hematological and biochemical profiles in mule and horse neonates from birth to 30 days of age: a comparative study with clinical perspectives.

Hematological and biochemical profiles in mule and horse neonates from birth to 30 days of age: a comparative study with clinical perspectives.

Journal: Journal of equine veterinary science

Published: December 19, 2025

Hematological and Biochemical Profiles in Mule and Horse Neonates from Birth to 30 Days of Age: A Comparative Study with Clinical Perspectives.

Hematological and Biochemical Profiles in Mule and Horse Neonates from Birth to 30 Days of Age: A Comparative Study with Clinical Perspectives.

Journal: Journal of equine veterinary science

Published: December 19, 2025

Progress in the Genetics of Myelodysplastic Syndromes with a Latin American Perspective.

Progress in the Genetics of Myelodysplastic Syndromes with a Latin American Perspective.

Journal: Genes

Published: April 17, 2025

Human Voltage-Activated H+ Channel is Highly Expressed in Acute Myeloid Leukemia and is Associated With the Blast Differentiated Stage.

Human Voltage-Activated H+ Channel is Highly Expressed in Acute Myeloid Leukemia and is Associated With the Blast Differentiated Stage.

Journal: Archives of medical research

Published: November 21, 2024

Clinical characteristics, prognosis, and achievement of transplant in adolescents and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in Argentina.

Clinical characteristics, prognosis, and achievement of transplant in adolescents and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in Argentina.

Journal: Hematology, transfusion and cell therapy

Published: September 27, 2024

Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemia.

Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemia.

Journal: Annals of hematology

Published: July 05, 2024

Assessing the Relevance of Non-molecular Prognostic Systems for Myelodysplastic Syndrome in the Era of Next-Generation Sequencing.

Assessing the Relevance of Non-molecular Prognostic Systems for Myelodysplastic Syndrome in the Era of Next-Generation Sequencing.

Journal: Annals of laboratory medicine

Published: February 16, 2024

Alternative Dosing Schedules of Azacitidine: A Real-World Study Across South American Centers.

Alternative Dosing Schedules of Azacitidine: A Real-World Study Across South American Centers.

Journal: Clinical lymphoma, myeloma & leukemia

Published: December 30, 2023

Derivation of two human induced pluripotent stem cell lines carrying a missense mutation in FHL1 (c.377G > A, p.C126Y) linked to familial muscular dystrophy.

Derivation of two human induced pluripotent stem cell lines carrying a missense mutation in FHL1 (c.377G > A, p.C126Y) linked to familial muscular dystrophy.

Journal: Stem cell research

Published: December 01, 2023

Generation of two edited iPSCs lines by CRISPR/Cas9 with point mutations in PKP2 gene for arrhythmogenic cardiomyopathy in vitro modeling.

Generation of two edited iPSCs lines by CRISPR/Cas9 with point mutations in PKP2 gene for arrhythmogenic cardiomyopathy in vitro modeling.

Journal: Stem cell research

Published: April 19, 2023

PH negative acute lymphoblastic leukemia in adolescents and young adults treated according a MRD adapted BFM ALL IC 2009 protocol: Argentine real-world data on 171 patients.

PH negative acute lymphoblastic leukemia in adolescents and young adults treated according a MRD adapted BFM ALL IC 2009 protocol: Argentine real-world data on 171 patients.

Journal: Annals of hematology

Published: October 13, 2022

Efficacy of lenalidomide in a patient with systemic mastocytosis associated with SF3B1-mutant myelodysplastic syndrome.

Efficacy of lenalidomide in a patient with systemic mastocytosis associated with SF3B1-mutant myelodysplastic syndrome.

Journal: Leukemia & lymphoma

Published: June 21, 2021

Showing 1-12 of 35

Last Updated: 09/26/2026